Display options
Share it on

J Tehran Heart Cent. 2017 Jan;12(1):27-31.

Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review.

The journal of Tehran Heart Center

Seyed Mohsen Mirhosseini, Ali Sanjari Moghaddam, Paritash Tahmaseb Pour, Ali Dabbagh

Affiliations

  1. Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 28469689 PMCID: PMC5409946

Abstract

Postoperative vasoplegic syndrome (VS) is characterized by low systemic vascular resistance, normal or elevated cardiac output, and poor response to volume expansion. The incidence of VS after cardiac surgery requiring cardiopulmonary bypass is about 20%. Sometimes, VS becomes refractory and initial treatments do not work, rendering treatment a great challenge. In this study, we describe a young male patient with endocarditis undergoing tricuspid valve replacement. When being weaned off cardiopulmonary bypass, the patient experienced VS. The patient's blood pressure did not increase after the administration of a high dose of epinephrine and norepinephrine. Therefore, he was commenced on a low dose of vasopressin and gradually his blood pressure reached the normal range. Although the standard management of VS is a high dose of vasopressors, this patient was refractory to a combination of epinephrine and norepinephrine; only a vasopressin infusion was able to treat the patient. Eventually, he was weaned from bypass and the operation was terminated satisfactorily. Thereafter, the patient passed the recovery period in the cardiac intensive care unit and was discharged. It seems that vasopressin is an excellent option in refractory vasoplegia with minimal response to other vasopressors.

Keywords: Endocarditis; Syndrome; Vasopressins

References

  1. Semin Cardiothorac Vasc Anesth. 2010 Sep;14(3):186-9 - PubMed
  2. Can J Cardiol. 2003 Feb;19(2):167-9 - PubMed
  3. PLoS One. 2013 Dec 10;8(12):e82214 - PubMed
  4. Korean J Anesthesiol. 2012 Aug;63(2):142-8 - PubMed
  5. Arq Bras Cardiol. 2006 Oct;87(4):525-32 - PubMed
  6. J Crit Care. 2014 Feb;29(1):83-7 - PubMed
  7. N Engl J Med. 2001 Aug 23;345(8):588-95 - PubMed
  8. Eur J Cardiothorac Surg. 2005 Nov;28(5):705-10 - PubMed
  9. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD003408 - PubMed
  10. Mini Rev Med Chem. 2008 May;8(5):472-90 - PubMed
  11. Rev Med Chil. 2011 Mar;139(3):368-72 - PubMed
  12. J Thorac Cardiovasc Surg. 2014 Aug;148(2):625-30 - PubMed
  13. Curr Pharm Des. 2012;18(38):6308-13 - PubMed
  14. J Thorac Cardiovasc Surg. 2003 Jun;125(6):1426-31 - PubMed
  15. J Cardiothorac Vasc Anesth. 2015 Feb;29(1):46-51 - PubMed
  16. Ann Fr Anesth Reanim. 2012 May;31 Suppl 1:S18-21 - PubMed
  17. Expert Rev Cardiovasc Ther. 2011 Dec;9(12):1519-25 - PubMed
  18. Anestezjol Intens Ter. 2009 Jul-Sep;41(3):159-62 - PubMed
  19. Curr Opin Crit Care. 2007 Aug;13(4):383-91 - PubMed
  20. Cardiovasc Revasc Med. 2011 Jul-Aug;12(4):203-9 - PubMed
  21. Eur J Cardiothorac Surg. 2002 Oct;22(4):527-33 - PubMed
  22. Circulation. 2009 Oct 27;120(17):1664-71 - PubMed
  23. Ann Thorac Surg. 2004 Feb;77(2):496-9 - PubMed
  24. J Cardiothorac Vasc Anesth. 2013 Aug;27(4):809-15 - PubMed
  25. J Cardiothorac Vasc Anesth. 2011 Aug;25(4):736-8 - PubMed
  26. Crit Care Res Pract. 2012;2012:621496 - PubMed
  27. AANA J. 2012 Jun;80(3):170-3 - PubMed
  28. Crit Care. 2011;15(5):R255 - PubMed
  29. Semin Thorac Cardiovasc Surg. 2010 Summer;22(2):140-4 - PubMed
  30. Ann Thorac Surg. 2014 May;97(5):1785-6 - PubMed
  31. Anesth Analg. 2012 Jun;114(6):1368; author reply 1369 - PubMed
  32. Ann Thorac Surg. 2005 May;79(5):1615-9 - PubMed
  33. A A Case Rep. 2014 May 1;2(9):113-4 - PubMed
  34. J Perianesth Nurs. 2010 Oct;25(5):290-5 - PubMed
  35. Am J Med Sci. 2015 Jan;349(1):80-8 - PubMed
  36. J Extra Corpor Technol. 2008 Sep;40(3):206-14 - PubMed
  37. J Emerg Med. 2014 May;46(5):670-9 - PubMed
  38. Ann Thorac Surg. 2009 Feb;87(2):640-2 - PubMed

Publication Types